Tag Archives: Trial
Pluristem (PSTI) Receives FDA Clearance for Intermittent Claudication Phase II Clinical Trial
Pluristem (PSTI) Receives FDA Clearance for Intermittent Claudication Phase II Clinical Trial Video Rating: 0 / 5
Clinical Trial Results of New Agent for Myelodysplastic Syndromes and Acute Myeloid Leukemia
Raoul Tibes, MD, Ph.D., hematologist and scientist at Mayo Clinic in Arizona, discusses Phase I clinical trial results of a new agent, SGI-110, a DNA hypomethylating agent, for the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML). The … Continue reading
First Patient Enrolled in CSL Behring PATH Trial to Evaluate Immune Globulin Subcutaneous (Human) 20 – PR-USA.net
Monitor patients for reactions associated with IVIg treatment that might occur with Hizentra, including renal dysfunction/failure, thrombotic events, aseptic meningitis syndrome (AMS), hemolysis and transfusion-related acute lung injury (TRALI). Bing News – Full Story →
Shire Reaffirms Support of Patients Requiring Midodrine HCl; Advances FDA Agreed Upon Clinical Trial – PR-USA.net
ProAmatine(R) is contraindicated in patients with severe organic heart disease, acute renal disease, urinary retention, pheochromocytoma or thyrotoxicosis. ProAmatine(R) should not be used in patients with persistent and excessive supine hypertension. Bing News – Full Story →
Incyte announces further analyses from Jakafi Phase III trial on myelofibrosis – News-Medical.Net
Abstract 278 Harrison C, et al. Ruxolitinib provides reductions in splenomegaly across subgroups: an analysis of spleen response in the COMFORT-II study. Abstract 279 Mesa R, et al. Associations between improvements in myelofibrosis (MF … Bing News – Full Story … Continue reading
Weitz & Luxenberg Trial Attorney Shareef Rabaa to Provide Expertise at Traumatic Brain Injury Conference – YAHOO!
Better educating juries about traumatic brain injuries will be the focus of a Dec. 4-6 conference in Denver that promises to attract many of the nation’s leading medical and legal experts on neurological and emotional injuries. A major summit will … Continue reading
Telik Announces Initiation of a Phase 2b Clinical Trial of Telintra® (Ezatiostat HCL) in Patients Wi – PR-USA.net
The company’s most advanced drug candidate is Telintra®, a modified glutathione analog intended for the treatment of hematologic disorders including myelodysplastic syndrome; followed by Telcyta®, a cancer activated prodrug for the treatment of a variety of cancers. Bing News – … Continue reading
Neurocrine starts another Phase II trial of tardive dyskinesia drug – North County Times
Neurocrine Biosciences Inc. said Monday that it has started a second Phase II clinical trial of its drug to treat tardive dyskinesia, a movement disorder. The drug, labeled NBI-98854 while it’s being tested, controls the release of dopamine, a … … Continue reading
Patient Enrollment Completed in Phase 2 Trial with RGN-259 for the Treatment of Dry Eye – Yahoo Finance
ROCKVILLE, Md.–(BUSINESS WIRE)– RegeneRx Biopharmaceuticals, Inc. (OTC Bulletin Board:RGRX.ob – News) (“the Company” or “RegeneRx”) today announced that all 72 patients have been enrolled in the Company’s Phase 2 clinical trial with RGN-259 for … Bing News – Full Story … Continue reading
Top-Line Results from Pivotal Trial of Dermagraft® for Venous Leg Ulcers – Phramalive.com
Westport, Conn. – August 24, 2011–Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced that Advanced BioHealing (ABH), its regenerative medicine business, has concluded its phase three pivotal trial of … Bing News – Full Story … Continue reading
